Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GamFluVac Safety and Immunogenicity in Healthy Volunteers
NCT04034290Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Jun 2020
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of GamFluVac in Influenza A (IAV). Started Oct 2019; status: completed.
02
Drugs
GamFluVac
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT04034290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034290.